Novavax Shares Surge 22% as Sanofi Begins Nuvaxovid Vaccine Distribution

Key Facts

1Novavax shares surged 22% as Sanofi began carrying the Nuvaxovid COVID-19 shot into the fall vaccination season.

2Novavax stock reached $12 during afternoon trading, significantly outperforming the broader biotech sector.

Novavax shares surged 22% as Sanofi began carrying the Nuvaxovid COVID-19 shot into the fall vaccination season. According to 247wallst.com, the stock reached $12 during afternoon trading, significantly outperforming the broader biotechnology sector.

The market reaction follows the commercial execution of a licensing agreement where Sanofi handles the distribution of the vaccine. Regarding peer performance, MRNA closed at $190.01 on October 2, 2026, and SNYNF closed at $77.98 on the same date, while NVAX had previously closed at $10.46 on October 2, 2026, prior to the latest rally.